Orbimed Advisors LLC Aadi Bioscience, Inc. Transaction History

Orbimed Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$16.65 - $24.97 $2.12 Million - $3.19 Million	-127,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.32 - $29.02 $4.22 Million - $6.35 Million	-218,662 Reduced 63.15%	127,600 $3.08 Million
Q3 2021 Nov 15, 2021	BUY	$25.52 - $41.85 $8.84 Million - $14.5 Million	346,262 New	346,262 $10.2 Million

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $44.3M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.